Cited by 385Cardiac Fibrosis and RemodelingTGF-β signaling in diseasesCongenital heart defects research

Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction

Open access
Dobaczewski, Marcin, Bujak, Marcin, Li, Na, Gonzalez-Quesada, Carlos, Mendoza, Leonardo H., Wang, Xiao-Fan, Frangogiannis, Nikolaos G.·2010·Circulation Research

Abstract

Rationale: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-β/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Objective: The present study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Methods and Results: Smad3 null mice and corresponding wild-type controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3−/− infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effects were mediated via Smad3. Smad3−/− fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared with wild-type cells. Decreased contractile function was associated with attenuated TGF-β–induced expression of α-smooth muscle actin. In addition, Smad3−/− fibroblasts had decreased migratory activity on stimulation with serum, and exhibited attenuated TGF-β1–induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor, an essential downstream mediator in TGF-β–induced fibrosis, was in part dependent on Smad3. Connective tissue growth factor stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Conclusions: Disruption of Smad3 results in infiltration of the infarct with abundant hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.109.216101

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts; fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype.

    “Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”

    From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [48]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G.
Affiliations
  • Duke University (US)
  • From the Section of Cardiovascular Sciences (M.D., M.B., N.L., C.G.-Q., L.H.M., N.G.F.), Department of Medicine, Baylor College of Medicine, Houston, Tex; and the Department of Pharmacology and Cancer Biology (X.-F.W.), Duke University Medical Center, Durham, NC.
Venue
Circulation Research
Published
2010-08-06
Volume
107
Issue
3
Pages
418-428
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2167721417
Cited by
385
References
40
Citations by year
2026: 21 · 2025: 16 · 2024: 27 · 2023: 23 · 2022: 29 · 2021: 33 · 2020: 22 · 2019: 27 · 2018: 28 · 2017: 36 · 2016: 18 · 2015: 29 · 2014: 19 · 2013: 27 · 2012: 20
FWCI
12.51
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL-76246, R01 HL85440, R01HL085440, R01HL076246)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
Smad3, TGF-beta signaling, cardiac fibroblasts, myocardial fibrosis, myofibroblast transdifferentiation, fibroblast proliferation, collagen deposition, alpha-smooth muscle actin, connective tissue growth factor, extracellular matrix, fibroblast migration, diastolic dysfunction
MeSH terms
Animals, Cell Differentiation, Cell Division, Cell Movement, Fibroblasts, Myocardial Contraction, Myocardial Infarction, Phenotype, Wound Healing, Trans-Activators, Up-Regulation, Extracellular Matrix Proteins, Mice, Knockout, Mice, Smad3 Protein, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review